GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » Net Change in Cash

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Net Change in Cash : $-1.20 Mil (TTM As of Sep. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Yew Bio-Pharm Group Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Yew Bio-Pharm Group's Net Change in Cash for the three months ended in Sep. 2021 was $-0.14 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2021 was $-1.20 Mil.

Yew Bio-Pharm Group Net Change in Cash Historical Data

The historical data trend for Yew Bio-Pharm Group's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yew Bio-Pharm Group Net Change in Cash Chart

Yew Bio-Pharm Group Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.40 0.58 -0.34 0.22 -0.18

Yew Bio-Pharm Group Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -0.66 -0.44 0.04 -0.14

Yew Bio-Pharm Group Net Change in Cash Calculation

Yew Bio-Pharm Group's Net Change in Cash for the fiscal year that ended in Dec. 2020 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=17.34+-17.356+-0.014+-0.148
=-0.18

Yew Bio-Pharm Group's Net Change in Cash for the quarter that ended in Sep. 2021

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=5.895+-5.642+-0.262+-0.129
=-0.14

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yew Bio-Pharm Group Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Yew Bio-Pharm Group's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » Net Change in Cash
Comparable Companies
SIAF URYL SUWN SGLAD OGAA ADX:IHC ADM SZSE:002714 TSN SHSE:600438 SGX:F34 BG SZSE:300498 OSL:MOWI BOM:543458 SZSE:000876 OSL:SALM XKLS:2445 XKLS:1961 BKK:CPF
Traded in Other Exchanges
N/A
Address
9460 Telstar Avenue, Suite 6, El Monte, CA, USA, 91731
Website
http://www.yewbiopharm.com
Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.
Executives
Yongchun Shi director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91302
Xiefeng Liu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Guoshuang Tian director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xuehai Wu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xingming Han director DOOR 3, FLOOR 7, VIC NO.23 TONGZHAN ST. XIANGFANG DISTRICT HARBIN CITY F4 XXXXXXXXX
Adam C Wasserman officer: Chief Financial Officer 1643 ROYAL GROVE WAY, WESTON FL 33327
Guifang Qi director, officer: Treasurer 501 N. MOORE AVE. APT. A MONTEREY PARK CA 91754
Zhiguo Wang director, officer: President and Secretary NO. 234, GEXIN STREET NANGANG DISTRICT HARBIN CITY F4 XXXXXXXXX

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Headlines

From GuruFocus

Yew Bio-Pharm Group Announces New Cosmetic Subsidiary

By Marketwired Marketwired • 03-09-2021

Yew Bio-Pharm Group Announces Submission of its Application to List on the Nasdaq

By Marketwired Marketwired • 09-25-2018

Yew Bio-Pharm Group Announces New Significant Agreement

By Marketwired Marketwired • 09-12-2018